MedPath

The effect of a long lasting pain block for open heart surgery - The PAIN Trial

Phase 1
Conditions
Acute postoperative pain after coronary bypass grafting surgery.
MedDRA version: 20.1Level: LLTClassification code 10054711Term: Postoperative painSystem Organ Class: 100000004863
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2021-005886-41-DK
Lead Sponsor
Aarhus University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients undergoing first-time, non-emergent coronary artery bypass grafting including harvest of the left internal mammary artery through a median sternotomy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 60

Exclusion Criteria

Emergent treatment (<24 hours)

Prior sternotomy or cardiac surgery

Concurrent heart surgery other than arrythmia surgery (i.e lung vein ablation and/or left appendage closure)

Daily use of opioids within the last 6 month prior to enrollment

Preoperative regular use of corticosteroids

Known allergy or intolerance to any of the included drugs

Woman of childbearing age without negative pregnancy test and nursing women

Any known condition that might interfere with the used drugs

Known impaired kidney function (defined as eGFR < 30 ml/min)

Active participation in another interventional trial with potential impact on postoperative pain and/or respiratory function

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To evaluate the efficacy and safety of long-acting local infiltration anesthesia in patients undergoing coronary bypass grafting through sternotomy. ;Secondary Objective: Not applicable;Primary end point(s): Primary endpoint is accumulated opioid consumption <br>;Timepoint(s) of evaluation of this end point: Cummulative dose within the first 24 postoperative hours
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): 1. Patient-reported pain <br>2. Time to first mobilization and pain during so <br>3. Peak flow <br>4. Ability to ambulate <br>5. Requirement of opioid medication;Timepoint(s) of evaluation of this end point: 1. at rest and coughing after extubation and within the first 24 hours after surgery <br>2. Time of first event.<br>3. 24 hours postoperative <br>4. 24 hours postoperative <br>5. at discharge, at 4 weeks and at 6 months
© Copyright 2025. All Rights Reserved by MedPath